Press Releases

Date	Title	Company
13-Jul-2022	PharmiWeb.Jobs Welcomes Excelya	PharmiWeb.Jobs
13-Jul-2022	Bioprocess Containers Market Global Industry Insights and Forecast, 2019 to 2028	Axiom Market Research & Consulting
13-Jul-2022	ABBOTT RECEIVES FDA'S BREAKTHROUGH DEVICE DESIGNATION TO EXPLORE USE OF DEEP BRAIN STIMULATION TO MANAGE SEVERE DEPRESSION	ABBOTT
13-Jul-2022	Gilead Sciences Appoints Deborah Telman as Executive Vice President, Corporate Affairs and General Counsel	Gilead Sciences
13-Jul-2022	Original-Research: MagForce AG (von GBC AG)	MagForce AG
13-Jul-2022	Extension of the postponement of the settlement of Vifor Pharma tender offer	Businesswire
13-Jul-2022	Caixa Capital Risc leads €5.5M Series A funding round for Zinklar	Andrew Lloyd Associates
13-Jul-2022	Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate	Heidelberg Pharma AG
13-Jul-2022	Zinklar raises €5.5M in Series A to accelerate global rollout of its insights automation platform	Andrew Lloyd Associates
13-Jul-2022	Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU	Relief Therapeutics Holding SA
13-Jul-2022	Gerresheimer AG: Gerresheimer on track to deliver record financial year 2022 after solid second quarter	Gerresheimer AG
13-Jul-2022	Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World's First Clinical Trial Utilizing Blockchain Technology	Businesswire
13-Jul-2022	Humanigen Receives Preliminary Topline Data From NIH/NIAID Study of Lenzilumab in ACTIV-5/BET-B	Businesswire
13-Jul-2022	Biocom California Applauds Supervisor Holly Mitchell and LA County Board of Supervisors for Expanding Life Sciences Industry Support and Creation of Equitable, High-road Career Opportunities for Local Communities	Businesswire
12-Jul-2022	SQZ Biotechnologies and Collaborators Publish Technology Review on SQZ® APCs and Effective CD8 T Cell Activation	Businesswire
12-Jul-2022	Atara Biotherapeutics Announces Completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS	Businesswire
12-Jul-2022	Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy	Businesswire
12-Jul-2022	AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022	Businesswire
12-Jul-2022	Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal of Medicinal Chemistry	Businesswire
12-Jul-2022	IGEA Pharma N.V.: IGEA PHARMA HAS ANNOUNCED THAT LMH - AN INDUSTRIAL HOLDING COMPANY - HAS COMPLETED THE DUE DILIGENCE PROCESS FOR A EURO 6.000.000 COMMITTMENT TO FUND THE SWISS CBD EXTRACTION FACILIT	IGEA Pharma N.V.